- Representing a major generic pharmaceutical company asserting antitrust and breach of contract claims against the branded manufacturer for steps taken to block generic entry.
- Trial counsel for a Fortune 500 global communications company in a standard essential patent licensing dispute.
- Represented multiple Fortune 500 food and beverage manufacturers and distributers in national product labeling class actions.
- Obtained regulatory approval for LHC Group Inc.’s $5.4 billion acquisition by UnitedHealth Group after counselling client through Second Request by Federal Trade Commission.
- Represented a cybersecurity technology company in arbitration asserting breach of contract claims against a reseller and defended against counterclaims worth hundreds of millions of dollars with favorable results for the client.
- Counsel for a major generic pharmaceutical company in a consumer class action alleging antitrust violations based on nondisclosure of essential patents to the U.S. Pharmacopeial Convention. (M.D.Tenn.).
- Defended a major pharmaceutical company in a Department of Justice investigation into alleged price fixing and market allocation in the generic pharmaceutical industry.
- Trial counsel defending a major insurance company in a certified RICO class action lawsuit where the claimed damages were approximately $9 billion; the case settled for less than 3 percent of the damages after a jury was empanelled. (S.D.Ill.).
Senior Associate,
- Phone: +1 404 881 7256
- Email: troy.stram@alston.com
Both plaintiffs and defendants rely on Troy’s litigation experience to provide creative solutions for their high-stakes commercial disputes.
Troy Stram is a senior associate in the Litigation & Trial Practice Group. He represents clients in a wide range of complex litigation and arbitration involving commercial disputes, antitrust, RICO, and consumer-protection statutes, with a particular focus on the pharmaceutical and food and beverage industries. Troy represents and advises clients through DOJ criminal investigations and advises clients on antitrust issues related to joint ventures and mergers and acquisitions, including filings under the HSR Act and substantive merger reviews by the Federal Trade Commission.
Troy is active in the American Bar Association’s (ABA) Section of Antitrust Law and serves on the Long-Range Planning Committee.
Troy earned his J.D., magna cum laude, from the University of Georgia School of Law. He served as an editorial board member of the Georgia Law Review and was awarded Best Oralist in the Georgia’s Intrastate Moot Court Competition. Troy was also inducted into the Order of the Coif.
-
For Your Consumption - Food & Beverage Digest March 2025For Your Consumption – March 2025: always reading the tea leavesWelcome to the latest edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This quarter, there’s nothing natural about beavers’ anal glands, we say “tomato” and plaintiffs say “citric acid is synthetic,” and someone must have said “PDCAAS” three times. Bon appétit!For Your Consumption - Food & Beverage Digest March 2025For Your Consumption – March 2025: always reading the tea leavesWelcome to the latest edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This quarter, there’s nothing natural about beavers’ anal glands, we say “tomato” and plaintiffs say “citric acid is synthetic,” and someone must have said “PDCAAS” three times. Bon appétit!
-
Class Action MDL Roundup March 26, 2025Class Action & MDL Roundup 2024 Q4 – We give you the benefit of the bargainIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2024, an overdue audiobook suit is shelved, an old case gets new reps and new evidence, and face-swappers get SLAPPed. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup March 26, 2025Class Action & MDL Roundup 2024 Q4 – We give you the benefit of the bargainIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2024, an overdue audiobook suit is shelved, an old case gets new reps and new evidence, and face-swappers get SLAPPed. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
For Your Consumption - Food & Beverage Digest January 2025For Your Consumption – January 2025: heavy metals rock onWelcome to the latest edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This quarter, toddlers are not babies, gummies decompose when exposed, and malic acid is peachy. Bon appétit!For Your Consumption - Food & Beverage Digest January 2025For Your Consumption – January 2025: heavy metals rock onWelcome to the latest edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This quarter, toddlers are not babies, gummies decompose when exposed, and malic acid is peachy. Bon appétit!
-
Class Action MDL Roundup January 3, 2025Class Action & MDL Roundup 2024 Q3 – Our market research is sustainableIn this edition, it’s not a breach if it isn’t stolen, a greenwashing claim is washed away, and a district court’s denial swims with the fishes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup January 3, 2025Class Action & MDL Roundup 2024 Q3 – Our market research is sustainableIn this edition, it’s not a breach if it isn’t stolen, a greenwashing claim is washed away, and a district court’s denial swims with the fishes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
For Your Consumption - Food & Beverage Digest December 2024For Your Consumption – December 2024: same as it ever was (or would be)
Welcome to the latest edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This quarter, words mean what they say, whisky still isn’t malt liquor, and there s’more wheat in graham crackers. Bon appétit!
We’ve changed the label, but you’ll find the same great ingredients inside.
For Your Consumption - Food & Beverage Digest December 2024For Your Consumption – December 2024: same as it ever was (or would be)Welcome to the latest edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This quarter, words mean what they say, whisky still isn’t malt liquor, and there s’more wheat in graham crackers. Bon appétit!
We’ve changed the label, but you’ll find the same great ingredients inside.
-
Press Release November 15, 2024Alston & Bird Secures Litigation Win for SandozOn November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC). In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC’s brand-name hypertension drug Remodulin to muscle out Sandoz’s generic alternative. Following a three-day bench trial, U.S. District Judge Brian R. Martinotti found Sandoz lost profits of $137.2 million and entered a judgment in favor of Sandoz, awarding damages of $61.6 million, plus prejudgment interest of $8.9 million, on its breach of contract claim against UTC. The win was featured in The American Lawyer’s Litigator of the Week, Law360’s Legal Lions column, and The New Jersey Law Journal.Press Release November 15, 2024Alston & Bird Secures Litigation Win for SandozOn November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC). In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC’s brand-name hypertension drug Remodulin to muscle out Sandoz’s generic alternative. Following a three-day bench trial, U.S. District Judge Brian R. Martinotti found Sandoz lost profits of $137.2 million and entered a judgment in favor of Sandoz, awarding damages of $61.6 million, plus prejudgment interest of $8.9 million, on its breach of contract claim against UTC. The win was featured in The American Lawyer’s Litigator of the Week, Law360’s Legal Lions column, and The New Jersey Law Journal.
-
Class Action MDL Roundup October 2, 2024Class Action & MDL Roundup 2024 Q2 – We are administratively feasibleIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2024, there can be only one claim form for many, broiler chickens are coming home to roost, and there is no conspiracy of memes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup October 2, 2024Class Action & MDL Roundup 2024 Q2 – We are administratively feasibleIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2024, there can be only one claim form for many, broiler chickens are coming home to roost, and there is no conspiracy of memes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Press Release August 29, 2024Alston & Bird Earns 16 Leadership Appointments to ABA Antitrust Law SectionSixteen Alston & Bird Antitrust Team attorneys have been appointed to leadership posts in the American Bar Association Antitrust Law Section, the country’s largest and most prominent antitrust and consumer protection bar organization.Press Release August 29, 2024Alston & Bird Earns 16 Leadership Appointments to ABA Antitrust Law SectionSixteen Alston & Bird Antitrust Team attorneys have been appointed to leadership posts in the American Bar Association Antitrust Law Section, the country’s largest and most prominent antitrust and consumer protection bar organization.
-
Class Action MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
For Your Consumption - Food & Beverage Digest June 13, 2024Food & Beverage Digest – June 2024: juicier than everWelcome to the latest edition of the Food & Beverage Digest, our roundup of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This month, we ponder the significance of insignificant, real cheese fans seek cheddar, and three plaintiffs have just one word: microplastics. Bon appétit!For Your Consumption - Food & Beverage Digest June 13, 2024Food & Beverage Digest – June 2024: juicier than everWelcome to the latest edition of the Food & Beverage Digest, our roundup of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries. This month, we ponder the significance of insignificant, real cheese fans seek cheddar, and three plaintiffs have just one word: microplastics. Bon appétit!
Bar Admissions
- Georgia
Education
- University of Georgia (J.D., 2017)
- Johns Hopkins University (M.S., 2014)
- Pennsylvania State University (B.A., B.S., 2014)